Avantor Inc at Morgan Stanley Global Healthcare Conference Transcript
All right. Good afternoon, everyone. My name is Tejas Savant, and I'm the life science tools and diagnostics analyst at Morgan Stanley. It's my pleasure to host Avantor this afternoon. And with me is Michael Stubblefield. In the audience, we have Tom Szlosek, and CJ is out there somewhere as well. So welcome, guys, and thanks for doing this.
Before we get started, just a quick disclaimer that I need to read off over here. For important disclosures, please see the Morgan Stanley research disclosure website at morganstanley.com/researchdisclosures. And if you have any questions, do reach out to your Morgan Stanley sales rep.
Questions & Answers
So with that, Michael, it's been a very dynamic year for Avantor with a lot of moving pieces. So as you sit here today, what are some of your reflections on the business performance year-to-date?
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |